Amber
Brand Name(s):Prolia
Indication:Osteoporosis (prevention) in postmenopausal women at increased risk of fractures. Men with increase risk of fracture
Rationale:1,2,3,8
Considered:Nov-11
Review Date:Jun-22
Comments:
Drug Safety Update
Denosumab is associated with a risk of osteonecrosis of the jaw, osteonecrosis of the external auditory canal has also been reported with denosumab
June 2017